Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Dusseldorf - Delayed Quote EUR

Sensei Biotherapeutics Inc (407.DU)

Compare
0.4120
+0.0010
+(0.24%)
As of 12:31:45 PM GMT+1. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
32,482
37,064
50,188
37,482
18,713
Operating Income
-32,482
-37,064
-50,188
-37,482
-18,713
Net Non Operating Interest Income Expense
2,750
3,480
1,564
130
-1,689
Other Income Expense
-69
-517
36
558
302
Pretax Income
-29,801
-34,101
-48,588
-36,794
-20,100
Net Income Common Stockholders
-29,801
-34,101
-48,588
-36,794
-20,204
Diluted NI Available to Com Stockholders
-29,801
-34,101
-48,588
-36,794
-20,204
Basic EPS
-1.19
-1.22
-1.58
-1.33
-0.68
Diluted EPS
-1.19
-1.22
-1.58
-1.33
-0.68
Basic Average Shares
25,071.2720
27,952.8570
30,703.2950
27,710.6860
29,558.2520
Diluted Average Shares
25,071.2720
27,952.8570
30,703.2950
27,710.6860
29,558.2520
Total Operating Income as Reported
-32,482
-37,064
-50,188
-37,482
-19,451
Total Expenses
32,482
37,064
50,188
37,482
18,713
Net Income from Continuing & Discontinued Operation
-29,801
-34,101
-48,588
-36,794
-20,100
Normalized Income
-29,801
-33,799
-48,588
-37,361
-20,402
Interest Income
2,854
3,624
1,783
800
--
Interest Expense
104
144
219
670
1,689
Net Interest Income
2,750
3,480
1,564
130
-1,689
EBIT
-29,697
-33,957
-48,369
-36,124
-18,411
EBITDA
-28,377
-32,606
-47,022
-35,439
-18,202
Reconciled Depreciation
1,320
1,351
1,347
685
209
Net Income from Continuing Operation Net Minority Interest
-29,801
-34,101
-48,588
-36,794
-20,100
Total Unusual Items Excluding Goodwill
--
-302
--
567
302
Total Unusual Items
--
-302
--
567
302
Normalized EBITDA
-28,377
-32,304
-47,022
-36,006
-18,504
12/31/2020 - 2/15/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers